Efficacy of Atorvastatin in Chronic Subdural Haematoma
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This prospective, double-blind, randomized, placebo-controlled study aims to evaluate the
efficacy and safety of atorvastatin in patients with chronic subdural haematoma. The degree
of disability or dependence in daily activities, as well as surgical intervention or
recurrence, of the treatment and control groups will be compared.